Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- PMID: 18945920
- PMCID: PMC2606813
- DOI: 10.2337/dc08-9025
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
Abstract
The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it would be updated, based on the availability of new interventions and new evidence to establish their clinical role. The authors continue to endorse the principles used to develop the algorithm and its major features. We are sensitive to the risks of changing the algorithm cavalierly or too frequently, without compelling new information. An update to the consensus algorithm published in January 2008 specifically addressed safety issues surrounding the thiazolidinediones. In this revision, we focus on the new classes of medications that now have more clinical data and experience.
Figures
Comment in
-
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.Diabetes Care. 2009 Mar;32(3):e34; author reply e37-8. doi: 10.2337/dc08-2093. Diabetes Care. 2009. PMID: 19246585 No abstract available.
-
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.Diabetes Care. 2009 Mar;32(3):e35-6; author reply e37-8. doi: 10.2337/dc08-2275. Diabetes Care. 2009. PMID: 19246586 No abstract available.
-
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Response to Nathan et al.Diabetes Care. 2009 May;32(5):e58; author rely e59. doi: 10.2337/dc09-0125. Diabetes Care. 2009. PMID: 19407068 No abstract available.
-
A practice-based approach to the 2012 position statement of the American Diabetes Association and the European Association for the Study of Diabetes.Curr Med Res Opin. 2013 Jul;29(7):793-9. doi: 10.1185/03007995.2013.798637. Epub 2013 May 10. Curr Med Res Opin. 2013. PMID: 23614630
Similar articles
-
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetologia. 2009 Jan;52(1):17-30. doi: 10.1007/s00125-008-1157-y. Epub 2008 Oct 22. Diabetologia. 2009. PMID: 18941734
-
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetes Care. 2008 Jan;31(1):173-5. doi: 10.2337/dc08-9016. Diabetes Care. 2008. PMID: 18165348 No abstract available.
-
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetes Care. 2007 Jan;30(1):193; author reply 194-6. doi: 10.2337/dc06-1828. Diabetes Care. 2007. PMID: 17192374 No abstract available.
-
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetes Care. 2007 Jan;30(1):193-4. doi: 10.2337/dc06-2060. Diabetes Care. 2007. PMID: 17192373 No abstract available.
-
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.Diabetologia. 2006 Aug;49(8):1711-21. doi: 10.1007/s00125-006-0316-2. Diabetologia. 2006. PMID: 16802130 No abstract available.
Cited by
-
The performance of a very sensitive glucose sensor developed with copper nanostructure-supported nitrogen-doped carbon quantum dots.RSC Adv. 2024 Nov 1;14(47):34964-34970. doi: 10.1039/d4ra06566b. eCollection 2024 Oct 29. RSC Adv. 2024. PMID: 39493548 Free PMC article.
-
Patient tolerance and acceptance of colesevelam hydrochloride: focus on type-2 diabetes mellitus.P T. 2015 Jan;40(1):62-7. P T. 2015. PMID: 25628509 Free PMC article.
-
Pharmacogenetics in type 2 diabetes: potential implications for clinical practice.Genome Med. 2011 Nov 29;3(11):76. doi: 10.1186/gm292. Genome Med. 2011. PMID: 22126607 Free PMC article.
-
Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.Drug Saf. 2012 Apr 1;35(4):315-23. doi: 10.2165/11596510-000000000-00000. Drug Saf. 2012. PMID: 22376166
-
The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.Drug Saf. 2013 Sep;36(9):733-46. doi: 10.1007/s40264-013-0038-6. Drug Saf. 2013. PMID: 23549904
References
-
- American Diabetes Association: Standards of medical care in diabetes—2008 (Position Statement). Diabetes Care 31(Suppl. 1):S12–S54, 2008 - PubMed
-
- European Diabetes Policy Group: A desk-top guide to type 2 diabetes mellitus. Diabet Med 16:716–730, 1999 - PubMed
-
- National Institute for Clinical Excellence: Clinical guidelines for type 2 diabetes mellitus: management of blood glucose [article online], 2002. Available from http://www.nice.org.uk./Guidancet/CG66
-
- Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial. N Engl J Med 329:978–986, 1993 - PubMed
-
- Reichard P, Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309, 1993 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical